Montreal Health Innovations Coordinating Center
Seriant (formerly MHICC) is a Montreal-based full-service Clinical Research Organization providing 12 integrated clinical trial service modules — including decentralized trials, precision medicine, pharmacogenomics, and biobank — to pharmaceutical and biotechnology companies globally.
- Company typePrivate
- Founded2001
- HeadquartersMontreal, Canada
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Montreal Health Innovations Coordinating Center does
Seriant, formerly known as the Montreal Health Innovations Coordinating Center (MHICC), is a Montreal-headquartered, private full-service Clinical Research Organization (CRO) serving pharmaceutical and biotechnology companies globally. Founded in 2001 and operating with 51-100 employees, the company delivers 12 integrated service modules spanning the full clinical trial lifecycle: decentralized clinical trials, project management, clinical monitoring, biostatistics and programming, data management, regulatory affairs, medical and scientific writing, medical and safety oversight, pharmacovigilance, biobank, precision medicine and pharmacogenomics, and quality assurance. The company traces its origins to cardiology and has repositioned itself as a precision-medicence-focused CRO with 25+ years of operating history.
Montreal Health Innovations Coordinating Center firmographics
Firmographics- Name
- Montreal Health Innovations Coordinating Center
- Legal name
- Montreal Health Innovations Coordinating Center
- Website
- https://mhicc.org
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Seriant (formerly MHICC) is a Montreal-based full-service Clinical Research Organization providing 12 integrated clinical trial service modules — including decentralized trials, precision medicine, pharmacogenomics, and biobank — to pharmaceutical and biotechnology companies globally.
- Ownership category
- akta.pro rank
Montreal Health Innovations Coordinating Center industry classification
Industry- Product category
- Contract Research Organization (Clinical Research Services)
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro industry
- Clinical CROs (Phase I–IV)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)Pharmacovigilance, Risk Management & Medical Affairs CROsHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)Clinical Data Management, Biostatistics & Statistical Programming CROsHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)
Keywords
Where Montreal Health Innovations Coordinating Center is headquartered
LocationHeadquarters
- HQ city
- Montreal
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Montreal Health Innovations Coordinating Center business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: Full-service CRO providing comprehensive clinical trial management including project management, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, safety oversight, pharmacovigilance, and quality assurance. Revenue is generated through service contracts with pharmaceutical and biotech companies conducting clinical studies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Montreal Health Innovations Coordinating Center product offering
Product offeringCore offering
MHICC is a Contract Research Organization (CRO) that provides outsourced clinical trial services to biopharmaceutical and medical device companies. It delivers 12 service modules covering the full clinical trial lifecycle — from study design through regulatory submission — including study coordination, data management, biostatistics, regulatory affairs, pharmacovigilance, quality assurance, medical writing, site management, monitoring, central laboratory, and bioanalytical services.
Product overview
Montreal Health Innovations Coordinating Center operates as a full-service Clinical Research Organization (CRO) providing end-to-end clinical trial solutions. The portfolio consists of 12 distinct service modules that work together to support drug development from early phases through submission: Decentralized Clinical Trials enables remote patient participation; Project Management and Clinical Monitoring provide operational oversight; Biostatistics and Programming and Data Management handle analytical and data needs; Regulatory Affairs, Quality Assurance, and Pharmacovigilance ensure compliance and safety; Medical and Scientific Writing and Medical and Safety Oversight deliver clinical expertise; and Precision Medicine and Pharmacogenomics combined with Biobank services enable biomarker-driven, targeted therapy development.
Differentiator
Problem solved
Functional benefit
Products and services
- End-to-end clinical trial management services (12 service modules) Integrated Contract Research Organization service offering covering the full clinical trial lifecycle across 12 modules, including study coordination, data management, biostatistics, regulatory affairs, pharmacovigilance, quality assurance, medical writing, site management, monitoring, central laboratory, and bioanalytical services. Delivered to biopharmaceutical and medical device sponsors.
Companies that use Montreal Health Innovations Coordinating Center
Customer profileSegments2 records
Ideal customer profiles1 record
Montreal Health Innovations Coordinating Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Montreal Health Innovations Coordinating Center partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Montreal Health Innovations Coordinating Center competitors and assessment
Company assessmentBroad incumbents
- Syneos Health: Global biopharmaceutical solutions organization offering clinical and commercial services. Competes with Seriant for full-service clinical trial engagements from large sponsors.
- Parexel International: Tier-1 global CRO providing full-service clinical research and biopharmaceutical services. Broader incumbent competing for many of the same pharma and biotech sponsors.
- Catalent (now part of Novo Holdings): Large global development and manufacturing organization with clinical services. Operates broadly in drug development and overlaps with Seriant's clinical research service portfolio.
- Charles River Laboratories: Large nonclinical and clinical CRO/CDMO serving pharma and biotech. Overlaps with Seriant in clinical research services and is a broader incumbent in the development services market.
Direct peers
- Advanced Clinical: Mid-market CRO providing clinical research, biometrics, and functional service support to pharma and biotech. Direct peer in the full-service mid-size CRO segment.
- Medpace: Mid-size full-service CRO focused on therapeutic-area expertise and global trial execution. Comparable to Seriant as a smaller, science-driven alternative to Tier-1 CROs.
- Altasciences: Canadian-headquartered mid-size CRO offering preclinical and clinical services. Closely comparable to Seriant in scale, geography, and full-service clinical trial offering.
Others
- Bioagile Therapeutics (biostatistics/data mgmt partner): Specialty provider of clinical data management and biostatistics services. Comparable on the narrower service modules Seriant offers (data management, biostatistics) rather than full-service trials.
Emerging players
- Pharmaron: China-rooted CRO/CDMO with growing global clinical research services. Comparable to Seriant as an emerging global CRO expanding its clinical research footprint.
- Celerion: Early-stage clinical CRO with emphasis on bioanalytical and Phase I capabilities. Comparable as a specialized mid-market clinical research services provider.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Montreal Health Innovations Coordinating Center social profiles
Digital presenceMontreal Health Innovations Coordinating Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
Montreal Health Innovations Coordinating Center leadership team
Management profileNumber of profiles
Profiles1 record
Montreal Health Innovations Coordinating Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Montreal Health Innovations Coordinating Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Montreal Health Innovations Coordinating Center
What does Montreal Health Innovations Coordinating Center do?
MHICC is a Contract Research Organization (CRO) that provides outsourced clinical trial services to biopharmaceutical and medical device companies. It delivers 12 service modules covering the full clinical trial lifecycle — from study design through regulatory submission — including study coordination, data management, biostatistics, regulatory affairs, pharmacovigilance, quality assurance, medical writing, site management, monitoring, central laboratory, and bioanalytical services.
Is Montreal Health Innovations Coordinating Center a public or private company?
Montreal Health Innovations Coordinating Center is a private company. It is classified as unknown and is currently operating.
When was Montreal Health Innovations Coordinating Center founded?
Montreal Health Innovations Coordinating Center was founded in 2001. It employs 51 to 100 people.
Where is Montreal Health Innovations Coordinating Center based?
Montreal Health Innovations Coordinating Center is headquartered in Montreal, Canada, in the North America region.
How does Montreal Health Innovations Coordinating Center make money?
One revenue line is on record: clinical Research Services.
Who are Montreal Health Innovations Coordinating Center's main competitors?
Broad incumbents on record are Syneos Health, Parexel International, Catalent (now part of Novo Holdings) and Charles River Laboratories. Direct peers are Advanced Clinical, Medpace and Altasciences. Bioagile Therapeutics (biostatistics/data mgmt partner) is listed as an others. Emerging players are Pharmaron and Celerion.
Does Montreal Health Innovations Coordinating Center have an API?
No public API is recorded for Montreal Health Innovations Coordinating Center.
What industry is Montreal Health Innovations Coordinating Center in?
Montreal Health Innovations Coordinating Center's product category is Contract Research Organization (Clinical Research Services). Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAH, Pharmacovigilance, Risk Management & Medical Affairs CROs. Its NAICS code is 54171 and its SIC code is 8071.